Universal Health (UHS) Tops Q4 EPS by 22c, Revenues Beat; Offers FY20 EPS/Revenue Guidance
Get Alerts UHS Hot Sheet
Price: $169.65 +0.26%
Revenue Growth %: +4.9%
Financial Fact:
Interest expense, net: 32.13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.9%
Financial Fact:
Interest expense, net: 32.13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Universal Health (NYSE: UHS) reported Q4 EPS of $2.79, $0.22 better than the analyst estimate of $2.57. Revenue for the quarter came in at $2.9 billion versus the consensus estimate of $2.87 billion.
GUIDANCE:
Universal Health sees FY2020 EPS of $10.30-$11.00, versus the consensus of $10.75. Universal Health sees FY2020 revenue of $11.96-12.116 billion, versus the consensus of $11.86 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share